Skip to main navigation Skip to search Skip to main content

Cancer pendant la grossesse: importance d'un registre national et Européen

  • M. Mhallem Gziri
  • , F. Goffin
  • , F. Debieve
  • , F. Amant
  • pre-AMC

Research output: Contribution to journalArticleProfessional

Abstract

Cancer during pregnancy is relatively rare, but its incidence has been increasing over recent years. A European study has been launched in 2005 by F. Amant (KUL) to register all pregnant patients with a cancer diagnosis with or without treatment during pregnancy (surgery, chemotherapy and/or radiotherapy). All infants exposed to chemotherapy and/or radiotherapy are also followed up by pediatricians, neurologists, cardiologists and psychologists. In Belgium, French- and Dutch- language hospitals are working in close collaboration to follow these pregnant patients. The national results are summarized in this paper
Original languageFrench
Pages (from-to)527-530
JournalRevue medicale de Liege
Volume68
Issue number10
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this